Navigation Links
Helping New Yorkers Prevent Heart Attacks: Itamar Medical Joins The Fight With New Campaign
Date:11/8/2013

NEW YORK, Nov. 8, 2013 /PRNewswire/ -- In response to the disturbing fact that people are more likely to die of a heart attack in New York City than anywhere else in the U.S., medical device company Itamar Medical (TASE: ITMR), today announced the launch of its first-ever initiative in the U.S. to increase awareness of endothelial (arterial) function testing and the importance of early detection in preventing heart attacks, particularly for symptomatic patients. The New York area was selected as the first city to kick off "Don't Ignore Your EndoScore" The campaign rolls out in New York the week of November 11.

The campaign will focus on providing information and options to help individuals, families and communities to best maximize their heart health, and will include testing with Itamar's EndoPAT test at participating New York-based hospitals and medical practices. To further promote heart health among families, the company also is offering a voucher program that provides for a second free test for a family member or loved one whenever someone takes an EndoPAT test during the month of November

"Testing for endothelial health plays an early and important role in stratifying cardiovascular risk," said Steven Lamm, MD, Clinical Assistant Professor, Department of Medicine (GIM Division), New York University School of Medicine, Director, Men's Health, NYU Medical Center. "The clinical value of this testing has been confirmed in many peer-reviewed studies, and it has been incorporated into regular use by many leading cardiologists around the world."

The EndoPAT test, an innovative, non-invasive FDA-approved medical device for measuring endothelial (arterial) function, is similar to having your blood pressure tested (both use a standard blood pressure cuff) and is easily performed in a physician's office or hospital setting. It measures endothelial (arterial) health, and provides reliable results in just 15 minutes.

The endothelium is the thin layer of cells that line the blood vessels. When these cells do not function properly, known as endothelial dysfunction, the arteries begin to lose their ability to supply more blood to the heart muscle when needed. Insufficient blood supply to the heart muscle can cause chest pain and other symptoms, such as shortness of breath, and can eventually lead to a heart attack if not properly managed.

"Getting an early diagnosis and taking preventative measures is critical in combating heart disease," said Gilad Glick, CEO, Itamar Medical. "We look forward to launching this campaign to raise awareness of arterial function and help more people gain access to a valuable test that, ultimately, gives them greater control over their heart health."

For more information on the "Don't Ignore Your EndoScore" campaign and to schedule an EndoPAT test at a participating hospital or physician's office, individuals can visit www.prevent-heartattack.com or call 1-855-PATMyHeart.

About Heart Attacks
Each year, about 715,000 Americans have a heart attack; of these, 525,000 are a first occurrence. Groups that are at particular risk are families with a history of heart disease, those with a previous heart attack or evidence of heart disease, and those who face tremendous workplace stress.

According to one study, if a member of your immediate family – father, mother, brother or sister – has had a heart attack before the age of 55, your risk is increased by 33 percent; if two relatives have had a heart attack, your risk is increased by 50 percent.

What most people don't realize is that a heart attack is largely preventable through early detection. Of the approximate 360,000 sudden cardiac deaths which occurred in the US last year, over half had no symptoms or risk factors.  Individuals who have had a heart attack are four to six times more likely to die of another heart attack despite getting medical treatment. According to the American Heart Association, half of men and more than half of women who experienced a sudden cardiac death did so without any prior warning signs.

About Itamar Medical
Established in 1997, Caesarea, Israel-based Itamar Medical (TASE: ITMR) is a medical device company which develops, markets and sells diagnostic medical devices based on the PAT™ (Peripheral Arterial Tone) signal.  The PAT signal is a non-invasive "window" to the cardiovascular system and the autonomic nervous system.

The company's EndoPAT™ is an innovative diagnostic tool that gives doctors and patients a window to the current functioning of the endothelium and the overall health of the heart.  The non-invasive diagnostic tool is the only medical device indicated for use in endothelial function assessment. WatchPAT is an FDA-approved portable diagnostic device that uses the most innovative technology to ensure the accurate screening, detection, and the follow-up on treatment of sleep apnea.

Itamar Medical ranks 14th in the Deloitte Fast 50 for 2008, with a five year growth of 1,915%. Deloitte Fast 50 is an annual list of the fastest growing companies in Israel.

For more information, please visit www.itamar-medical.com.

Media Contact:
Craig Heit, GCI Health
(212) 798-9919
craig.heit@gcihealth.com


'/>"/>
SOURCE Itamar Medical
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BD Launches BD Helping Build Healthy Communities with Direct Relief and the National Association of Community Health Centers
2. Henry Schein "Back to School Program" Focuses on Helping Children Start the New Year With Confidence and Motivation to Succeed
3. Theres a Robot Helping People who Suffer from Hip Pain
4. In Observance of Veterans Day Reproductive Medicine Associates of New Jersey Extends "Helping Heroes Build Families" Program
5. CVS/pharmacy Helping Customers in Stores and Online to Weather Hurricane Sandy
6. Helping Start-Ups Avoid Slow-Downs
7. Multiple Sclerosis Association of Americas MRI Institute Marks 10 Years of Helping Individuals with Multiple Sclerosis Obtain MRIs
8. NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic™ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels
9. New Yorkers Test Stilts Fitted with Prosthetic Feet
10. Preventing Heart Disease One Step at a Time
11. Sorrento Therapeutics Enters into Antibody and Vaccine Development Alliance for the Prevention and Treatment of Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Research and Markets has announced the addition of the "Hemophilia ... ... Drugs Price Analysis and Strategies - 2016, provides drug pricing data and ... questions: What are the key drugs marketed ... Global Hemophilia market? What are the unit prices and ...
(Date:2/24/2017)... , Feb. 24, 2017 Juan ... & Associates PC , a boutique securities firm headquartered ... York City , announces that a class action ... Massachusetts  against Inotek Pharmaceuticals Corporation (NASDAQ: ... the Company,s securities between July 23, 2015 and December 30, ...
(Date:2/24/2017)... Feb. 23, 2017  Directors from Pharma To Market Pty Ltd ... joined forces, resulting in the founding of Pharma To Market Pte ... To Market are pleased to announce their expansion into ... Singapore . The company are delighted to appoint ... the Singapore based entity. Joelle brings with ...
Breaking Medicine Technology:
(Date:2/27/2017)... , ... February 27, 2017 , ... ... Shamanic Healing and Spiritual Awakening, is happy to announce her “Spring Rejuvenation ... and body, these individual customized retreats offer the winter-weary soul an excellent opportunity ...
(Date:2/27/2017)... ... February 27, 2017 , ... The threat of nuclear warfare has ... a company involved in the underground testing of nuclear weapons. Years later, when her ... Workers of the Cold War Nuclear Testing,” Clayton exposes the critical decisions made by ...
(Date:2/27/2017)... ... 27, 2017 , ... Orange County dentist, Dr. A. Rassouli, comments ... occurs when the bacteria in plaque infect the gums and other tissues supporting the ... root planing or SRP, and can include surgical therapies if the condition has led ...
(Date:2/27/2017)... ... , ... Miro is the ultimate smart media center that offers a fascinating ... shows and much more apps for user exploration. Its innovative acoustic design with premium ... x 720 provides crisp images with remarkable clarity and color. The WiFi connection enables ...
(Date:2/27/2017)... Houston, TX (PRWEB) , ... February 27, 2017 ... ... the 75,000 customer threshold mark last week. In addition, Discount Power's RCE (Residential ... Volterra Energy LLC in March 2014. The company had 800 customers and 2,250 ...
Breaking Medicine News(10 mins):